Legend Biotech Corp 6-K, filed Jan 9, 2024
Legend Biotech Corp (LEGN)
6-K
2024-01-09
For: 2024-01-09
View Original
Added on
April 07, 2026
About this 6-K
Legend Biotech Corp filed this 6-K on January 9, 2024.
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 6-K
Report of Foreign Private Issuer
Pursuant to Rule 13a-16 or 15d-16
of the Securities Exchange Act of 1934
Date of Report: January 9, 2024
Commission File Number: 001-39307
Legend Biotech Corporation
(Exact Name of Registrant as Specified in its Charter)
2101 Cottontail Lane
Somerset, New Jersey 08873
(Address of principal executive office)
Indicate by check mark whether the registrant files or will file annual reports under cover of Form 20-F or Form 40-F:
Form 20-F ☒ Form 40-F ☐
Indicate by check mark if the registrant is submitting the Form 6-K in paper as permitted by Regulation S-T Rule 101(b)(1): ☐
Indicate by check mark if the registrant is submitting the Form 6-K in paper as permitted by Regulation S-T Rule 101(b)(7): ☐
Legend Biotech Updates Corporate Presentation at the 42nd Annual J.P. Morgan Healthcare Conference
On January 9, 2024, Legend Biotech Corporation (“Legend Biotech” or the “Company”) will make its updated corporate presentation available on its website.
The presentation is attached to this Form 6-K as Exhibit 99.1 and may be viewed on the Company’s website at https://investors.legendbiotech.com/events-and-presentations.
This report on Form 6-K (except information contained
on, or that can be accessed through, our website), including Exhibit 99.1, shall be deemed to be incorporated by reference in the registration statements of Legend Biotech on Form F-3 (Nos. 333-272222, 333-257609 and 333-257625) and Form S-8 (No. 333-239478), to the extent not superseded by
documents or reports subsequently filed.
EXHIBIT INDEX
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its
behalf by the undersigned, thereunto duly authorized.
|
|
|
LEGEND BIOTECH CORPORATION
|
|
|
|
|
|
|
|
Date: January 9, 2024
|
|
By:
|
/s/ Ying Huang
|
|
|
|
Name:
|
Ying Huang, Ph.D.
|
|
|
|
Title:
|
Chief Executive Officer
|
Exhibit 99.1
